Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Dexamethasone/Piperacillin/tazobactam - Yuhan Corporation

Next Previous
Drug Profile

Dexamethasone/Piperacillin/tazobactam - Yuhan Corporation

Alternative Names: YH-1177; YH-1177D

Latest Information Update: 29 Sep 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Yuhan
  • Class 2 ring heterocyclic compounds; Anti-infectives; Antibacterials; Carboxylic acids; Penicillins; Piperazines; Small molecules; Sulfones; Triazoles; Urinary anti-infective agents
  • Mechanism of Action Beta lactamase inhibitors; Cell wall inhibitors; Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Otitis media

Most Recent Events

  • 29 Sep 2021 Discontinued - Phase-I/II for Otitis media in South Korea (Otic) prior to September 2021 (Yuhan Corporation pipeline, September 2021)
  • 13 Apr 2017 Yuhan Corporation terminates a phase I/II trial in Otitis media in South Korea (Otic) (NCT02817347)
  • 01 Jul 2016 Yuhan Corporation plans a phase I/II trial for Otitis media in South Korea (NCT02817347)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top